Crimean-Congo hemorrhagic fever in Turkey: Current status and future challenges

Leblebicioglu H., Ozaras R., Irmak H., Sencan I.

ANTIVIRAL RESEARCH, vol.126, pp.21-34, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 126
  • Publication Date: 2016
  • Doi Number: 10.1016/j.antiviral.2015.12.003
  • Journal Name: ANTIVIRAL RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.21-34
  • Keywords: Crimean-Congo hemorrhagic fever, Turkey, Epidemic preparedness, Tick-borne disease, Arbovirus, Ribavirin, BLACK-SEA REGION, VIRAL LOAD, NOSOCOMIAL TRANSMISSION, RIBAVIRIN TREATMENT, ENDEMIC REGION, RISK-FACTORS, VIRUS, EFFICACY, IMPACT, CCHF
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne viral disease of humans that affects a wide geographic area of Africa and Eurasia, including Turkey, Iran, Pakistan, Afghanistan and Russia. Since the first detection of CCHF cases in Turkey in 2002, more than 9700 patients have been reported, with an overall mortality rate just under 5%. This article assesses the present epidemiological situation of CCHF in Turkey, with an updated literature review, describes national practices and summarizes lessons learned in preparation for future outbreaks. (C) 2015 Elsevier B.V. All rights reserved.